{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:07:27Z","timestamp":1781672847656,"version":"3.54.5"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,21]]},"DOI":"10.7759\/cureus.9322","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T19:43:12Z","timestamp":1595360592000},"source":"Crossref","is-referenced-by-count":1,"title":["Positive Response to Fluorouracil and Oxaliplatin in Signet Ring Cell Adenocarcinoma of the Bladder Presenting with Retroperitoneal Fibrosis"],"prefix":"10.7759","author":[{"given":"Sanjay","family":"Hinduja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifaa","family":"Abdulhaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salimah","family":"Valliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1971.tb04925.x","article-title":"A study of 52 cases of adenocarcinoma of the bladder","volume":"43","author":"Thomas DG","year":"1971","unstructured":"Thomas DG, Ward AM, Williams JL. A study of 52 cases of adenocarcinoma of the bladder. Br J Urol. 1971, 43:4-15. 10.1111\/j.1464-410x.1971.tb04925.x","journal-title":"Br J Urol"},{"key":"ref2","article-title":"Pure primary signet ring cell carcinoma of the bladder: atypical case and review of the literature","volume":"1","author":"Armache K","year":"2014","unstructured":"Armache K, Feghali J, Bourgi A, Chemaly AK, Aftimos G, Moukarzel M. Pure primary signet ring cell carcinoma of the bladder: atypical case and review of the literature. Urol Nephrol Open Access J. 2014, 1:70-72.","journal-title":"Urol Nephrol Open Access J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7796.95555","article-title":"CA 19-9 as a serum marker in urothelial carcinoma","volume":"4","author":"Pall M","year":"2012","unstructured":"Pall M, Iqbal J, Singh SK, Rana SV. CA 19-9 as a serum marker in urothelial carcinoma. Urol Ann. 2012, 4:98-101. 10.4103\/0974-7796.95555","journal-title":"Urol Ann"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/915874","article-title":"Long-term survival of a patient with invasive signet-ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy","volume":"2013","author":"Hamakawa T","year":"2013","unstructured":"Hamakawa T, Kojima Y, Naiki T, et al.. Long-term survival of a patient with invasive signet-ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy. Case Rep Urol. 2013, 2013:915874. 10.1155\/2013\/915874","journal-title":"Case Rep Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000282745","article-title":"Primary signet ring cell carcinoma of the urinary bladder. Review of the literature and report of two cases","volume":"55","author":"Erdogru T","year":"1995","unstructured":"Erdogru T, Kilicaslan I, Esen T, Ander H, Ziylan O, Uysal V. Primary signet ring cell carcinoma of the urinary bladder. Review of the literature and report of two cases. Urol Int. 1995, 55:34-37. 10.1159\/000282745","journal-title":"Urol Int"},{"key":"ref6","article-title":"Signet-ring cell carcinoma of the urinary bladder mimicking retroperitoneal fibrosis","volume":"105","author":"Iqbal MA","year":"2006","unstructured":"Iqbal MA, Lawatsch EJ, Coyle DJ, Rowe JJ, Li R, Dua KS, Kochar MS. Signet-ring cell carcinoma of the urinary bladder mimicking retroperitoneal fibrosis. WMJ. 2006, 105:55-58.","journal-title":"WMJ"},{"key":"ref7","article-title":"Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis","volume":"189","author":"Dayyani F","year":"2012","unstructured":"Dayyani F, Czerniak BA, Sircar K, Munsell MF, Millikan RE, Dinney CP, Siefker-Radtke AO. Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. J Urol.  2012, 189:1656-1661.","journal-title":"J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.06.065","article-title":"Primary signet-ring cell carcinoma of the urinary bladder","volume":"75","author":"Akamatsu S","year":"2010","unstructured":"Akamatsu S, Takahashi A, Ito M, Ogura K. Primary signet-ring cell carcinoma of the urinary bladder. Urology. 2010, 75:615-618. 10.1016\/j.urology.2009.06.065","journal-title":"Urology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/24756-positive-response-to-fluorouracil-and-oxaliplatin-in-signet-ring-cell-adenocarcinoma-of-the-bladder-presenting-with-retroperitoneal-fibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:08Z","timestamp":1707506888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/24756-positive-response-to-fluorouracil-and-oxaliplatin-in-signet-ring-cell-adenocarcinoma-of-the-bladder-presenting-with-retroperitoneal-fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.9322","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,21]]}}}